A detailed history of Northwest Quadrant Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Northwest Quadrant Wealth Management, LLC holds 2,927 shares of LLY stock, worth $2.25 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
2,927
Previous 2,924 0.1%
Holding current value
$2.25 Million
Previous $2.65 Million 2.04%
% of portfolio
0.6%
Previous 0.65%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$772.14 - $960.02 $2,316 - $2,880
3 Added 0.1%
2,927 $2.59 Million
Q2 2024

Jul 12, 2024

BUY
$724.87 - $909.04 $2,174 - $2,727
3 Added 0.1%
2,924 $2.65 Million
Q1 2024

Apr 12, 2024

BUY
$592.2 - $792.28 $2,368 - $3,169
4 Added 0.14%
2,921 $2.27 Million
Q4 2023

Jan 09, 2024

BUY
$525.19 - $619.13 $1,575 - $1,857
3 Added 0.1%
2,917 $1.7 Million
Q3 2023

Oct 10, 2023

BUY
$434.7 - $599.3 $1,738 - $2,397
4 Added 0.14%
2,914 $1.57 Million
Q2 2023

Aug 03, 2023

BUY
$350.74 - $468.98 $2,104 - $2,813
6 Added 0.21%
2,910 $1.36 Million
Q1 2023

Apr 10, 2023

BUY
$310.63 - $364.82 $2,174 - $2,553
7 Added 0.24%
2,904 $997,000
Q4 2022

Jan 30, 2023

BUY
$321.55 - $374.67 $1,607 - $1,873
5 Added 0.17%
2,897 $1.06 Million
Q3 2022

Oct 12, 2022

SELL
$296.48 - $337.87 $161,581 - $184,139
-545 Reduced 15.86%
2,892 $935,000
Q2 2022

Aug 04, 2022

BUY
$278.73 - $327.27 $71,633 - $84,108
257 Added 8.08%
3,437 $1.12 Million
Q1 2022

Apr 08, 2022

BUY
$234.69 - $291.66 $1,642 - $2,041
7 Added 0.22%
3,180 $927,000
Q4 2021

Jan 26, 2022

BUY
$224.85 - $279.04 $1,573 - $1,953
7 Added 0.22%
3,173 $876,000
Q3 2021

Oct 13, 2021

BUY
$221.6 - $272.71 $1,551 - $1,908
7 Added 0.22%
3,166 $729,000
Q2 2021

Jul 20, 2021

BUY
$180.55 - $233.54 $1,083 - $1,401
6 Added 0.19%
3,159 $725,000
Q1 2021

Apr 14, 2021

SELL
$164.32 - $212.72 $40,915 - $52,967
-249 Reduced 7.32%
3,153 $589,000
Q4 2020

Jan 22, 2021

BUY
$130.46 - $172.63 $1,304 - $1,726
10 Added 0.29%
3,402 $568,000
Q3 2020

Oct 13, 2020

BUY
$146.22 - $169.13 $1,900 - $2,198
13 Added 0.38%
3,392 $496,000
Q2 2020

Jul 09, 2020

BUY
$136.42 - $164.18 $1,909 - $2,298
14 Added 0.42%
3,379 $550,000
Q1 2020

May 11, 2020

SELL
$119.05 - $147.35 $23,095 - $28,585
-194 Reduced 5.45%
3,365 $515,000
Q4 2019

Jan 21, 2020

BUY
$106.92 - $132.43 $1,603 - $1,986
15 Added 0.42%
3,559 $467,000
Q3 2019

Oct 24, 2019

SELL
$106.79 - $116.16 $1,815 - $1,974
-17 Reduced 0.48%
3,544 $382,000
Q2 2019

Jul 17, 2019

BUY
$110.79 - $129.32 $1,772 - $2,069
16 Added 0.45%
3,561 $397,000
Q1 2019

Apr 10, 2019

BUY
$111.31 - $131.02 $1,558 - $1,834
14 Added 0.4%
3,545 $458,000
Q4 2018

Feb 01, 2019

BUY
$105.9 - $118.64 $1,588 - $1,779
15 Added 0.43%
3,531 $406,000
Q3 2018

Nov 16, 2018

BUY
$85.86 - $107.31 $1,373 - $1,716
16 Added 0.46%
3,516 $387,000
Q2 2018

Aug 10, 2018

BUY
$75.7 - $86.88 $1,438 - $1,650
19 Added 0.55%
3,500 $299,000
Q1 2018

May 09, 2018

BUY
$74.21 - $87.6 $1,558 - $1,839
21 Added 0.61%
3,481 $269,000
Q4 2017

Feb 08, 2018

SELL
$81.94 - $87.89 $6,964 - $7,470
-85 Reduced 2.4%
3,460 $268,000
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $1,464 - $1,625
19 Added 0.54%
3,545 $294,000
Q2 2017

Aug 10, 2017

BUY
N/A
3,526
3,526 $289,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Northwest Quadrant Wealth Management, LLC Portfolio

Follow Northwest Quadrant Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Quadrant Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Quadrant Wealth Management, LLC with notifications on news.